Google
PRCT — PROCEPT BIOROBOTICS CORP (Healthcare >> Medical Devices)
PRCT FAQ
What is PRCT's ROE?
PROCEPT BIOROBOTICS CORP reports a Return on Equity (ROE) of -29.47%.
What is PRCT's dividend yield?
PROCEPT BIOROBOTICS CORP offers a dividend yield of 0.00%.
What is PRCT's Deepscope Quality Score?
Deepscope rates PRCT's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PRCT?
Deepscope's AI Timing Score for PRCT is 96 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PRCT belong to?
PROCEPT BIOROBOTICS CORP is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 27.00
Price
0.83
(3.07%)
Day Change
|
|
|---|
PRCT, the overall quality is not good ( Quality = 15) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.08 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 27.00 |
| PBV / Sector |
4.38 / 7.50
|
| Earning Per Share | -1.82 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
39.38 M
GREAT
|
| Average 1W Daily Value |
26.52 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:11:57 |
| Symbol | PRCT |
| Name | PROCEPT BIOROBOTICS CORP |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 56.92 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,523.15 / 18,060.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 150 Baytech Drive, San Jose, CA, United States, 95134
Phone: 650 232 7200
Website: https://www.procept-biorobotics.com
Employees: 888
Sector: Healthcare >> Medical Devices
Description: PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
